May 7, 2015 — NorthStar Medical Radioisotopes LLC has completed its first production-scale test run of the molybdenum-99 ...
May 4, 2015 — Results from Lantheus Medical Imaging Inc.’s first Phase 3 study of flurpiridaz F 18 for myocardial ...
April 30, 2015 — A first-in-human prostate cancer study in the Journal of Molecular Imaging and Biology showed initial ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
April 16, 2015 — A new four-year research study will determine the clinical usefulness and value of a brain positron ...
March 17, 2015 — NorthStar Medical Radioisotopes LLC will unveil the commercial model of its RadioGenix isotope ...
March 17, 2015 — The National Oncologic PET Registry (NOPR) Working Group submitted a formal request to the Centers for ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
March 10, 2015 — Using a mouse model of cancer, researchers at Washington University School of Medicine in St. Louis ...
March 10, 2015 — The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the ...
February 18, 2015 — Researchers at University Medical Center (UMC) Utrecht are developing an innovative cancer treatment ...
February 4, 2015 — Lantheus Medical Imaging Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ...
January 30, 2015 — The U.S. Food and Drug Administration (FDA) has approved for human evaluation a nanoparticle-based ...
January 30, 2015 — Lantheus Medical Imaging Inc. announced an agreement with the Institute for Radioelements (IRE) for ...
Nov. 13. 2014 — Coquí RadioPharmaceuticals Corp. (Coquí Pharma) is working to become the first commercial producer of ...
November 7, 2014 — Lantheus Medical Imaging Inc. and Shine Medical Technologies Inc. announced that the companies have ...
October 20, 2014 — A new analysis from the Phase III SELECT (Study of (E7080) LEnvatinib in Differentiated Cancer of the ...
October 16, 2014 — Navidea Biopharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has ...
October 15, 2014 – The Radiological Society of North America (RSNA) has received an additional $1.27 million of funding ...
October 1, 2014 — Newly published European Society for Medical Oncology (ESMO) clinical guidelines for the treatment of ...
September 30, 2014 — Coquí RadioPharmaceuticals Corp. is working to become the first commercial producer of lifesaving ...
September 29. 2014 — Navidea Biopharmaceuticals, Inc. has announced that that the Committee for Medicinal Products for ...